Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

1. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Шарҳ мақолаLipoproteins and Cardiovascular HealthAtherosclerosis20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000004

2. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Шарҳ мақолаDiabetes Treatment and ManagementClinica Chimica Acta20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000250